1. Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001; 14:177–207.
Article
2. Das M, Badley AD, Cockerill FR, Steckelberg JM, Wilson WR. Infective endocarditis caused by HACEK microorganisms. Annu Rev Med. 1997; 48:25–33.
Article
3. Wormser GP, Bottone EJ. Cardiobacterium hominis: review of microbiologic and clinical features. Rev Infect Dis. 1983; 5:680–691.
4. Meyer DJ, Gerding DN. Favorable prognosis of patients with prosthetic valve endocarditis caused by gram-negative bacilli of the HACEK group. Am J Med. 1988; 85:104–107.
Article
5. el Khizzi N, Kasab SA, Osoba AO. HACEK group endocarditis at the Riyadh Armed Forces Hospital. J Infect. 1997; 34:69–74.
Article
6. Tornos P, Sanz E, Permanyer-Miralda G, Almirante B, Planes AM, Soler-Soler J. Late prosthetic valve endocarditis. Immediate and long-term prognosis. Chest. 1992; 101:37–41.
7. Ellner JJ, Rosenthal MS, Lerner PI, McHenry MC. Infective endocarditis caused by slow-growing, fastidious, Gram-negative bacteria. Medicine (Baltimore). 1979; 58:145–158.
Article
8. Hall R, de Antueno C, Webber A; Canadian Research Ethics Board. Publication bias in the medical literature: a review by a Canadian Research Ethics Board. Can J Anaesth. 2007; 54:380–388.
Article
9. Geraci JE, Wilson WR. Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases. Mayo Clin Proc. 1982; 57:145–148.
10. Wang A, Athan E, Pappas PA, Fowler VG Jr, Olaison L, Paré C, Almirante B, Muñoz P, Rizzi M, Naber C, Logar M, Tattevin P, Iarussi DL, Selton-Suty C, Jones SB, Casabé J, Morris A, Corey GR, Cabell CH. International Collaboration on Endocarditis-Prospective Cohort Study Investigators. Contemporary clinical profile and outcome of prosthetic valve endocarditis. JAMA. 2007; 297:1354–1361.
Article
11. Goldsweig HG, Matsen JM, Castaneda AR. Hemophilus aphrophilus endocarditis in a patient with a mitral valve prosthesis. Case report and review of the literature. J Thorac Cardiovasc Surg. 1972; 63:408–411.
Article
12. Geraci JE, Wilkowske CJ, Wilson WR, Washington JA 2nd. Haemophilus endocarditis. Report of 14 patients. Mayo Clin Proc. 1977; 52:209–215.
13. Bieger RC, Brewer NS, Washington JA 2nd. Haemophilus aphrophilus: a microbiologic and clinical review and report of 42 cases. Medicine (Baltimore). 1978; 57:345–355.
14. Darras-Joly C, Lortholary O, Mainardi JL, Etienne J, Guillevin L, Acar J. Haemophilus endocarditis: report of 42 cases in adults and review. Haemophilus Endocarditis Study Group. Clin Infect Dis. 1997; 24:1087–1094.
15. Dickerman SA, Abrutyn E, Barsic B, Bouza E, Cecchi E, Moreno A, Doco-Lecompte T, Eisen DP, Fortes CQ, Fowler VG Jr, Lerakis S, Miro JM, Pappas P, Peterson GE, Rubinstein E, Sexton DJ, Suter F, Tornos P, Verhagen DW, Cabell CH, Investigators IC. The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS). Am Heart J. 2007; 154:1086–1094.
Article
16. Chambers ST, Murdoch D, Morris A, Holland D, Pappas P, Almela M, Fernández-Hidalgo N, Almirante B, Bouza E, Forno D, del Rio A, Hannan MM, Harkness J, Kanafani ZA, Lalani T, Lang S, Raymond N, Read K, Vinogradova T, Woods CW, Wray D, Corey GR, Chu VH; International Collaboration on Endocarditis Prospective Cohort Study Investigators. HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort. PLoS One. 2013; 8:e63181.
Article